DeepMed Research

The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Phase 1

Completed

Conditions: Cancer

First Posted Date: 2006-08-07

Last Posted Date: 2010-11-05

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 49

Registration Number: NCT00361049

Locations: 🇺🇸
Geauga Regional Hospital, Cleveland, Ohio, United States
🇺🇸
Lake/University Ireland Cancer Center, Cleveland, Ohio, United States
🇺🇸
Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

and more 5 locations

Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors

Completed

Conditions: Neurotoxicity
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2006-03-22

Last Posted Date: 2014-11-24

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 59

Registration Number: NCT00305799

Locations: 🇺🇸
MetroHealth Medical Center, Cleveland, Ohio, United States
🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer

Phase 1

Terminated

Conditions: Colorectal Cancer
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2006-02-24

Last Posted Date: 2012-01-16

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 12

Registration Number: NCT00296062

Locations: 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer

Completed

Conditions: Neurotoxicity
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2006-01-25

Last Posted Date: 2010-06-11

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 15

Registration Number: NCT00281853

Locations: 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Biological: bevacizumab
Drug: docetaxel
Procedure: conventional surgery
Radiation: radiation therapy

First Posted Date: 2006-01-25

Last Posted Date: 2015-06-09

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 30

Registration Number: NCT00281840

Locations: 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
UHHS Chagrin Highlands Medical Center, Orange Villager, Ohio, United States
🇺🇸
Lake/University Ireland Cancer Center, Mentor, Ohio, United States

and more 3 locations

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Completed

Conditions: Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases
Psychosocial Effects of Cancer and Its Treatment

First Posted Date: 2006-01-25

Last Posted Date: 2012-03-15

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 168

Registration Number: NCT00281801

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer

Phase 2

Completed

Conditions: Kidney Cancer

First Posted Date: 2006-01-18

Last Posted Date: 2011-05-04

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 7

Registration Number: NCT00278174

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: docetaxel
Drug: gemcitabine hydrochloride

First Posted Date: 2006-01-13

Last Posted Date: 2013-01-31

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 35

Registration Number: NCT00276549

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder

Phase 2

Completed

Conditions: Myelodysplastic/Myeloproliferative Diseases
Myelodysplastic Syndromes
Chronic Myeloproliferative Disorders
Leukemia

First Posted Date: 2006-01-11

Last Posted Date: 2020-07-27

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 15

Registration Number: NCT00274820

Locations: 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer

Phase 2

Completed

Conditions: Esophageal Cancer

Interventions: Drug: ZD1839

First Posted Date: 2005-12-22

Last Posted Date: 2016-01-05

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 58

Registration Number: NCT00268346

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy